The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zavedos 10 mg Hard Capsules



Pfizer Healthcare IrelandPA0822/142/002

Main Information

Trade NameZavedos 10 mg Hard Capsules
Active SubstancesIdarubicin hydrochloride
Dosage FormCapsule, hard
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/142/002

Group Information

ATC CodeL01DB Anthracyclines and related substances
L01DB06 idarubicin

Status

License statusWithdrawn
Withdrawn Date08/11/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back